Literature DB >> 33161065

The dietary fatty acids α-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide production.

Jessica R Lowry1, Nick Marshall1, Tyler J Wenzel1, Taryn E Murray1, Andis Klegeris2.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder without a known cure or effective treatment. Research has identified several modifiable risk factors and suggested preventative measures to reduce the risk of developing AD, including alterations in diet. Polyunsaturated fatty acids (PUFAs) have been shown to regulate inflammatory responses in the central nervous system (CNS), the main site of inflammation in AD. In the CNS, microglia are immune cells responsible for the maintenance of homeostasis. However, in AD, microglia can become adversely activated, causing them to release increased levels of cytotoxins and inflammatory mediators, including nitric oxide (NO) and monocyte-chemoattractant protein (MCP)-1. We assessed the effects of two PUFAs, α-linolenic acid (ALA) and linoleic acid (LA), on select microglial immune functions, since the effects of these dietary fatty acids on neuroimmune responses are not well characterized. In BV-2 mouse microglia activated with lipopolysaccharide (LPS), exposure to LA reduced NO secretion and inducible nitric oxide synthase (iNOS) levels, whereas exposure to ALA reduced NO without a corresponding reduction of iNOS. Neither ALA nor LA altered MCP-1 levels or cytotoxins released by THP-1 human microglia-like cells stimulated with a combination of LPS and interferon (IFN)-γ. Specific receptor antagonists were used to demonstrate that the inhibitory effect of LA on NO secretion did not depend on the free fatty acid receptor (FFAR) 1 or FFAR4. Furthermore, gas chromatography with a flame ionization detector (GC-FID) revealed that exposure to LA or ALA did not alter the fatty acid composition of BV-2 microglia. Our data indicate that regulation of select microglial immune functions by ALA and LA could be one of the mechanisms underlying the observed link between certain dietary patterns and AD, such as reduced risk of cognitive decline and dementia associated with the Mediterranean diet.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AH7614; Alzheimer's disease (AD); FFAR4; Free fatty acid receptor (FFAR) 1; GW1100; Polyunsaturated fatty acids (PUFAs)

Year:  2020        PMID: 33161065     DOI: 10.1016/j.mcn.2020.103569

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  3 in total

1.  α-Linolenic acid induces clearance of Tau seeds via Actin-remodeling in Microglia.

Authors:  Smita Eknath Desale; Subashchandrabose Chinnathambi
Journal:  Mol Biomed       Date:  2021-02-09

2.  Therapeutic Effects and Metabolic Spectrum of Traditional Chinese Medicine Hengqing II Prescription on Alzheimer's Disease.

Authors:  Shengxi Meng; Shaopeng Li; Huize Chen; Chujun Deng; Zeyu Meng; Yimo Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-02       Impact factor: 2.650

Review 3.  An Overview on Total Valorization of Litsea cubeba as a New Woody Oil Plant Resource toward a Zero-Waste Biorefinery.

Authors:  Yufei Qiu; Yasi Yu; Ping Lan; Yong Wang; Ying Li
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.